Clinical Research Directory

Inclusion Criteria: 1. Patients aged 12 to 65 years (inclusive) of either gender. 2. Clinical diagnosis of non-segmental vitiligo with depigmented area including ≥ 0.5% BSA on the face and total body vitiligo area not exceeding 20% BSA. 3. Fully understand the trial content, voluntarily participate in the trial, and sign the ICF. 4. Must be willing to take appropriate contraceptive measures to avoid pregnancy or fathering a child for the duration of study participation. \- Exclusion Criteria: 1. Other dermatoses that may complicate the assessment of vitiligo. 2. Previous depigmentation treatments (eg, monobenzone) for past treatment of vitiligo or other pigmented areas. 3. Use of protocol-defined treatments within the indicated washout period before baseline. 4. Liver or renal damage. 5. Allergic to any component of the investigational drug. 6. Pregnant or lactating subjects. -